Ethiopia is living through its worst malaria year in seven years. More than 7.3 million cases and over 1,150 deaths have been reported in 2026, close to double the 2023 figure (CIDRAP, 2026). The hardest part is still ahead: peak transmission follows the main rains and runs roughly September through December, so the demand for antimalarials, rapid tests, and vector-control commodities is building right now. For a hospital pharmacy or a wholesaler, the window to order and receive stock before the peak is the July-to-August period. This is the checklist to work through before the September surge.
Why 2026 is different, and why it will not ease with the rains
Three forces are pushing this outbreak. Vector-control funding has fallen, displacement has moved vulnerable populations into transmission zones, and the urban-adapted Anopheles stephensi mosquito is expanding the endemic map into towns that were previously low-risk (WHO Regional Office for Africa). Médecins Sans Frontières is already responding alongside the Ministry of Health in hard-hit areas of Oromia and Gambella. None of that reverses when the rains arrive. Rain fills the breeding sites, and cases climb weeks later, which is precisely why pre-positioning stock now beats reacting in October.
The malaria commodities to stock before September
- Rapid diagnostic tests (RDTs). Test-before-treat is the standard, and RDTs are the front line where microscopy is unavailable. Stock enough to cover a caseload that could double at peak.
- ACT antimalarials. Artemether-lumefantrine (commonly known as Coartem) is the first-line treatment for uncomplicated malaria. Order across the weight bands, not just the adult pack.
- Injectable artesunate. The treatment of choice for severe malaria. Hospitals must not run short of it during a surge.
- Supportive supplies. IV fluids, giving sets, and consumables for managing severe cases and dehydration.
- Vector-control items where you supply programmes: insecticide-treated nets and related commodities.
Lead time is the whole game
Most antimalarials and test kits are imported, and imported stock does not appear overnight. Between a purchase order, foreign-exchange arrangement, shipping, port clearance, and EFDA-permitted release, a fresh import can take weeks to months. If you place orders in September, you are competing for the same constrained supply as every other buyer who also waited. The facilities that will cope are the ones that ordered against a forecast in July, from a supplier already holding registered stock. Our guide to the pharmaceutical cold chain in Ethiopia covers how temperature-sensitive commodities should move so they arrive usable.
Buy quality, not just quantity
A surge is exactly when substandard and falsified antimalarials find their way into the market, because demand outstrips legitimate supply and buyers get desperate. A fake or under-dosed antimalarial does not just fail a patient; it fuels resistance. Insist on EFDA-registered products with batch documentation from every supplier, and treat an unusually low price as a warning rather than a win. We set out the full due-diligence process in how to verify a medicine supplier in Ethiopia, and the same discipline that protects your antibiotic supply, covered in our antibiotic sourcing guide, applies here.
LifeCare is an EFDA-licensed importer supplying hospitals, wholesalers, and programmes across Ethiopia, including rapid test kits and essential-medicine lines. If you are building your rainy-season order and want a supplier who can quantify and hold seasonal stock, get in touch before the peak.
